In re Fosamax Products Liability Litigation

OPINION & ORDER

JOHN F. KEENAN, District Judge:

Before the Court is a motion to dismiss brought by the Generic Manufacturer Defendants (“Generic Defendants”). For the reasons that follow, Generic Defendants’ motion is granted in part and denied in part.

I. Background

Plaintiffs in this case were prescribed Fosamax and its generic equivalent, alendronate sodium, an oral bisphosphonate. This MDL involves claims that Fosamax, manufactured by Merck, or its generic equivalent, manufactured by the Generic Defendants, caused users to suffer from a condition known as osteonecrosis of the jaw (“ONJ”).…